Dr. Charles Eric Wooten, MD

Dr. Wooten practices at MUSC Health Florence Medical Center in Florence, South Carolina, part of Medical University of South Carolina.

Dr. Wooten's NPI, 1497045058, was assigned on April 15, 2011. Dr. Wooten graduated from Mercer University School of Medicine in 2011. Dr. Wooten holds South Carolina license 29781.

Dr. Wooten's primary practice is MUSC Health Florence Medical Center, at 805 Pamplico Hwy Box 100550, Florence, SC 29505 in Florence County. The practice phone is (843) 674-2500.

Dr. Wooten's primary practice is MUSC Health Florence Medical Center in Florence, South Carolina, part of Medical University of South Carolina. Dr. Wooten is also affiliated with McLeod Regional Medical Center Florence. The medical group on file is MUSC Community Physicians. Dmand AI also links Dr. Wooten to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wooten practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Wooten's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Wooten's licenses on file in 2 states: South Carolina and Kentucky.

CMS data shows 2,356 Medicare services from Dr. Wooten across 17 procedure codes in 2024, for 154 Medicare patients. Medicare paid $169,072 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 154 Medicare patients who saw Dr. Wooten in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have cancer, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wooten's median patient age at 67, with 41% women.

In 2024, Dr. Wooten wrote 127 Medicare Part D claims for 52 patients. 61% of them were for generic drugs. CMS names the drug for 75 of them, across 3 drugs with 11 or more claims each, at $87,518 in total drug cost. In 2023, CMS named 61 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Wooten for performance year 2024, reported as part of a group. Dr. Wooten accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 76 general payments to Dr. Wooten from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $434.

Dr. Wooten graduated from Mercer University School of Medicine in 2011.